Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 11 - 15    tags : Drug    save search

NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
Published: 2022-11-15 (Crawled : 22:00) - globenewswire.com
NXTC | $1.46 -4.58% 86K twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.28% C: -6.59%

drug collaboration antibody agreement
Lyndra Therapeutics’ LYNX™ Drug Delivery Platform Wins 2022 Fierce Life Sciences Innovation Award for Drug Delivery Technology
Published: 2022-11-15 (Crawled : 21:00) - biospace.com/
GILD | $66.81 -0.33% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 0.61% C: -0.16%

award sciences drug life technology innovation platform
Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates
Published: 2022-11-15 (Crawled : 13:00) - globenewswire.com
ONVO | $1.005 0.5% 110K twitter stocktwits trandingview |
Health Technology
| | O: 6.96% H: 0.0% C: -2.96%

drug disease
Zynerba Pharmaceuticals Announces European Commission Has Granted Orphan Drug Designation for Zygel™ in 22q11.2 Deletion Syndrome
Published: 2022-11-15 (Crawled : 13:00) - ir.zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
| | O: -1.83% H: 5.66% C: 3.53%

pharmaceuticals designation drug granted
Calliditas' partner Everest Medicine's New Drug Application for Nefecon is accepted by the China NMPA
Published: 2022-11-15 (Crawled : 08:00) - prnewswire.com
CALT | $18.5 1.65% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: 7.47% H: 2.36% C: 2.36%

drug application china nefecon
Everest Medicines Announces New Drug Application Acceptance by China NMPA for Nefecon for the Treatment of Primary IgA Nephropathy
Published: 2022-11-15 (Crawled : 01:00) - prnewswire.com
CALT | $18.5 1.65% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: 7.47% H: 2.36% C: 2.36%

treatment nephropathy drug application china nefecon
Gainers vs Losers
58% 42%

Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M twitter stocktwits trandingview |
Consumer Services

CZOO | $11.04 121.24% 11M twitter stocktwits trandingview |

LICN | $0.9107 62.63% 14M twitter stocktwits trandingview |

BOF | $1.87 59.83% 100M twitter stocktwits trandingview |

AMST | $3.18 59.0% 67M twitter stocktwits trandingview |
Technology Services

SKIL 4 | $8.72 52.72% 410K twitter stocktwits trandingview |
Information

MTC | $3.31 47.77% 7.7M twitter stocktwits trandingview |
Technology Services

MULN | News | $3.915 43.41% 12M twitter stocktwits trandingview |
Information

WIMI | $1.04 43.37% 17M twitter stocktwits trandingview |
Technology Services

RILY | $29.755 36.99% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.